Concepedia
Statistics
Publications
2
Citations
58
H-Index
Active since
2023
Affiliations
Institute of Chemistry(Current)
Nankai University
Chinese Academy of Sciences
Beijing National Laboratory for Molecular Sciences
Chinese PLA General Hospital
Dongquan Xiang is an author at Institute of Chemistry specializing in pharmacology, oncology, and nanoparticle-based chemotherapy.
Publications per year
2023–2023
Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
Dongquan Xiang, Xin-Li Han, Jianxiong Li et al. · Materials Today Bio · 2023 · 36 citations · Full text
Medicine, Oncology, Pharmacology +17
ROS responsive nanoparticles mediated inhibition of monocarboxylic acid transporters to enhance chemoimmunotherapy by overcoming low immune response in osteosarcoma
Xin-Li Han, Dongquan Xiang, Jianxiong Li et al. · Nano Today · 2023 · 22 citations
Medicine, Oncology, Pharmacology +16
1–2 of 2